Abstract-Strategies to enhance skeletal myoblast (SkM) survival after transplantation in the ischemic heart have achieved little success. We posit that preconditioned (PC) SkMs show improved survival and promote repair of the infarcted myocardium via paracrine signaling after transplantation. SkMs from male Fischer-344 rats (rSkMs) were PC for 30 minutes with 200 mol/L diazoxide. Treatment of PC rSkMs with 100 mol/L H 2 O 2 for 2 hours resulted in significantly reduced cell injury, as shown by lactate dehydrogenase-release assay, and prevented apoptosis, as demonstrated by cytochrome c translocation, TUNEL, annexin V staining, and preservation of mitochondrial membrane potential. PC rSkMs expressed elevated phospho-Akt (1.85-fold), basic fibroblast growth factor (1.44-fold), hepatocyte growth factor (2.26-fold), and cyclooxygenase-2 (1.33-fold) as compared with non-PC rSkMs. For in vivo studies, female Fischer-344 rats after permanent coronary artery ligation were grouped (nϭ12/group) to receive 80 L of basal medium without rSkMs (group 1) or containing 1.5ϫ10 6 non-PC (group 2) or PC (group 3) rSkMs. Real-time PCR for sry gene 4 days after transplantation (nϭ4/group) showed 1.93-fold higher survival of rSkMs in group 3 as compared with group 2. Four weeks later, echocardiography revealed improved indices of left ventricular function, including ejection fraction and fractional shortening in group 3 (PϽ0.02) as compared with groups 1 and 2. Blood vessel count per surface area (at ϫ400 magnification) was highest in scar and periscar areas in group 3 as compared with the other groups (PϽ0.05). We conclude that activation of signaling pathways of preconditioning in SkMs promoted their survival by release of paracrine factors to promote angiomyogenesis in the infarcted heart. Transplantation of PC SkMs for heart cell therapy is an innovative approach in the clinical perspective. (Circ Res. 2007;100:545-555.)
P roof-of-concept experimental animal studies and clinical trials have shown the suitability of SkM transplantation for treatment of cardiac and skeletal muscle-related pathologies. [1] [2] [3] Despite promising results, transplantation of SkMs is confronted with the problem of poor survival in the host myocardium. 4 A significantly high percentage of SkMs undergoes necrosis within hours after transplantation, thus compromising the optimal outcome of the procedure. In some studies, more than 70% to 80% of the cultured SkMs died within 3 days, 5, 6 whereas others have shown that 93% of SkMs were lost in 2 days after transplantation. 7 Pagani et al showed a meager 1% survival of the transplanted SkMs in patient hearts. 2 These disconcerting reports regarding the problematic poor survival of SkMs have implicated multiple factors for the extensive cell death in SkM transplantation studies. 8 Besides other mechanisms, the dynamics of early donor SkM death incriminates local tissue ischemia induced apoptosis as one of the prime factors. 4 Considering that cell survival may greatly enhance the effectiveness of transplantation therapy, several remedial approaches have been suggested. Physiologically relevant hyperthermia has been shown to selectively overexpress heat shock protein-70 in cardiac myoblasts and thus confers oxidative protection. 9 This approach was used by Suzuki et al to enhance SkM survival in a rat heart model. 10 Coadministration of cell types dedicated to varying potentials and different functions (myogenesis and angiogenesis) may help the donor cells survive better. Similarly, ex vivo gene modification of SkMs for overexpression of angiogenic growth factors stimulate survival signaling in them. 11 Administration of growth factors promoting angiogenesis would improve blood perfusion in the scar, thus leading to the longer term survival of the cell graft. In a more recent development, transgenic overexpression of cell survival signaling molecules including Akt promoted resistance of the donor cells against apoptosis in the infarcted myocardium. 12 To exploit the powerful cytoprotective nature of preconditioning approach, we posit that preconditioning of SkMs using preconditioning mimetics will enhance their resistance to ischemia induced apoptosis.
Ischemic preconditioning has been shown to improve tolerance in various body tissues including the heart. 13, 14 These effects have been mimicked via pharmacological intervention using mitochondrial potassium channel openers. [15] [16] [17] In vitro cellular models are currently being studied to elucidate the underlying molecular mechanisms involved in preconditioning-induced tolerance and antiapoptotic effects. 16, 18 The present study is novel in terms of combining the importance of cellular preconditioning with heart cell therapy to overcome the problem of extensive SkM death post transplantation.
Materials and Methods

Isolation and Culture of rSkMs
Under sedation, the site of skeletal muscle biopsy in hindlimbs of male Fischer-344 rats was stimulated with intramuscular injection of 0.3 mL mixture of ketamine (10 mg/mL) and xylazine (2 mg/mL). Three days later, an excisional biopsy (1 to 2 g) of the stimulated muscle was removed and processed for isolation of rSkMs. 19 Briefly, biopsy samples were minced into coarse slurry, followed by serial enzymatic digestion (at 37°C) with 0.2% collagenase type XI (GIBCO-BRL) for 90 minutes, 2.4 U/mL of dispase (GIBCO-BRL) for 45 minutes, and finally 0.1% trypsin-EDTA (GIBCO-BRL) for 15 minutes. The muscle extract was preplated 3 times at a 1-hour time interval and twice additionally at 8 and 16 hours to remove the debris and contaminating cells. After the last preplate, 0.1 mmol/L 5-bromodeoxyuridine (BD-Pharmingen) was added to the cell culture for 3 days to inhibit fibroblast growth followed by 3 days of treatment with 15 ng/mL basic fibroblast growth factor (bFGF) (Sigma). The cells were later propagated in medium-199 supplemented with 20% FBS at 37°C/5% CO 2 atmosphere, and purity of the culture was determined by desmin-specific immunostaining as described earlier. 11 The purified rSkM culture was repeatedly passaged at regular time intervals to prevent their premature differentiation in vitro. The present study conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes (NIH Publication No. 85-23, revised 1985) and protocol approved by the Institutional Animal Care and Use Committee, University of Cincinnati.
In Vitro Studies for Cytoprotective Effects of Preconditioning
Preconditioning of rSkMs and Oxidant Stress
The cells were grown on Petri dishes at a density of 3.75ϫ10 4 cells/cm 2 . One day later, they were randomly assigned to 3 experimental groups: non-PC rSkMs (group 1), non-PC rSkMs incubated with 100 mol/L H 2 O 2 for 2 hours (group 2), and rSkMs PC for 30 minutes with 200 mol/L diazoxide (DZ) (Sigma) and treated with 100 mol/L H 2 O 2 for 2 hours (group 3). The dose and time for H 2 O 2 and diazoxide treatment were determined from experiments shown in Figure IA and IB in the online data supplement, available at http://circres.ahajournals.org. All experiments were performed in serum-and glucose-free DMEM. At the end of the experiment, rSkMs and their supernatants were removed for molecular studies to assess cellular injury from oxidative stress and cytoprotective effects of preconditioning.
Lactate Dehydrogenase Leakage
Intracellular lactate dehydrogenase (LDH) leakage, a well-known indicator of cell membrane integrity and viability, was measured in the cell-conditioned medium samples using an LDH Assay kit (Diagnostic Chemicals Ltd) according to the instructions of the manufacturer. Detailed methods are available in the online data supplement.
Annexin V/Propidium Iodide Staining of rSkMs
The percentage of apoptotic, necrotic, and viable rSkMs in the different treatment groups was determined with the annexin V/propidium iodide (PI) Apoptosis Detection kit (Sigma) according to the instructions of the manufacturer. Fluorescence was detected by flow cytometry (FACSCalibur, BD). The apoptotic cells were stained with annexin V; necrotic cells displayed both PI and annexin V staining, whereas live cells remained unstained.
Mitochondrial Membrane Potential
Disruption of mitochondrial transmembrane potential in the early apoptotic cells was detected using DePsipher (R&D Systems Inc). DePsipher is a specific marker of mitochondrial activity. Staining of rSkMs with DePsipher was performed for 15 minutes at 37°C in a 5% CO 2 atmosphere, according to the instructions of the manufacturer, and visualized with a fluorescent microscope.
Cytochrome c-Specific Immunostaining
The integrity of mitochondrial membrane was detected by immunostaining for translocation of cytochrome c from mitochondria to the cytosol. rSkMs from various treatment groups were fixed with 4% paraformaldehyde for 10 minutes at room temperature. Immunostaining was performed using mouse anti-cytochrome c primary antibody (BD Pharmingen; 1:100) and goat anti-mouse secondary antibody (1:100) conjugated with Alexa Fluor-546 (Molecular Probes). The cells were visualized with Olympus BX41 microscope equipped with digital camera (Olympus) for punctate (live rSkMs) or diffused (early apoptotic rSkMs) fluorescence in the cytoplasm.
Terminal Deoxynucleotidyl Transferase-Mediated dUTP Nick-End Labeling
TUNEL on different treatment groups of cells was performed according to the instructions of the manufacturer (Roche, Indianapolis, Ind).
Reverse-Transcription Polymerase Chain Reaction
Isolation of total RNA from the different treatment groups of rSkMs, and their subsequent first-strand cDNA synthesis, was performed using an RNeasy mini kit (Qiagen) and an Omniscript Reverse Transcription kit (Qiagen), respectively, per the instructions of the manufacturer. The following primer sequences were used for PCR: 
Real-Time PCR for Donor Cell Survival in Rat Heart
The detailed methods for real-time PCR are available in the online data supplement.
Multiplex PCR
For detection of the rat GAPDH, Tie-2, cyclooxygenase (Cox)-2, angiopoietin-2 (Ang-2), Ang-1, and vascular endothelial growth factor (VEGF), an multiplex polymerase chain reaction kit (catalog no. MP70175) was used according to the instructions of the supplier (Maxim Biotech Inc). The following thermocycle profile was used: initial denaturation at 96°C for 1 minute and annealing at 58°C for 4 minutes, repeated twice; 30 cycles of denaturation at 94°C for 1 minute and annealing/extension at 58°C for 2 minutes and a final extension at 70°C for 10 minutes.
Western Immunoblotting
For protein expression, cells from various treatment groups were processed and analyzed by Western immunoblotting as detailed in the online data supplement.
In Vivo Studies
PKH-26 Labeling of rSkMs
Labeling of rSkMs with PKH26 dye to study their fate posttransplantation was performed using a PKH-26 Cell Linker Kit (Sigma) according to the instructions of the supplier.
Rat Heart Model of Acute Myocardial Infarction and Transplantation of rSkMs
Rats were anesthetized by intraperitoneal injection of ketamine/ xylazine (24 mg/kg and 4 mg/kg body weight, respectively). After endotracheal intubation and ventilation using Harvard Apparatus Rodent Ventilator (model no. 683), the heart was exposed via minimal left-sided thoracotomy. Left anterior descending coronary artery was ligated with Prolene 6.0 suture. Immediately after that, animals were grouped (nϭ12/group) to receive intramyocardial injections of 80 L of basal DMEM without rSkMs (group 1) or containing 1.5ϫ10 6 non-PC rSkMs (group 2) or PC rSkMs (group 3). The injections were performed at multiple sites (average of 4 to 5 sites/animal) in the free wall of the left ventricle (LV) under direct vision. The chests of animals were sutured, and animals were allowed to recover.
Physiological Assessment of Heart Function
Under general anesthesia, transthoracic echocardiography was performed using Compact Linear Array probe CL10 -5 on HDI/5000 SONOS CT (HP Co) to study change in the heart function, as described earlier. 20 
Immunohistochemical Studies
Immunostaining was performed as described previously. 11 Briefly, cells were fixed in 4% paraformaldehyde, blocked with 10% normal goat serum in PBS, and incubated with the respective primary antibody dissolved in blocking solution at a specified dilution of 1:100. The antibodies used were specific for desmin (Sigma), Ki67 and cytochrome c (BD Pharmingen), skeletal muscle myosin heavy chain (fast isoform) (AbCam), connexin 43 (Chemicon), and von Willebrand factor (vWF) VIII (Chemicon). The primary antigenantibody reaction was detected with goat anti-mouse IgG secondary antibody conjugated with Alexa Fluor-488 or Alexa Fluor-546 (1:100) or Alexa Fluor-546 goat anti-rabbit IgG (1:100) (Molecular Probes). The samples were examined using fluorescent microscope (BX41, Olympus, Tokyo, Japan).
For blood vessel density analysis, frozen histological sections (7-m thickness) were immunostained using antibodies specific for vWF VIII, as previously described. 20 The blood vessels positive for vWF VIII were counted in both infarct and periinfarct regions. At least 32 high-power microscopic fields (ϫ400) each in infarct and periinfarct regions were randomly selected and counted in each treatment group of animals (nϭ4 animals/group). Blood vessel density was expressed as the number of vessels per surface area (0.155 mm 2 ).
Statistical Analysis
All data were described as meanϮSEM. To analyze the data statistically, we performed Student's t test and 1-way ANOVA with post hoc analysis and considered a value of PϽ0.05 as statistically significant.
Results
Purification and Propagation of rSkMs
The purified rSkMs were characterized by their typical cytoskeleton, their peculiar wave-like alignment that radiates from a common origin, and their ability to form myotubes under low-serum concentration cell culture conditions. High purity of rSkM culture (Ͼ90%) was further confirmed by desmin expression (data not shown).
In Vitro Studies
Cytoprotective Effect of Preconditioning
The cumulative effect of insufficient nutrients, decreased oxygen availability, and lack of growth and survival factors make it harsh for cells to survive in the ischemic myocardium. We simulated these parameters in vitro by exposing rSkMs to culture conditions without glucose and serum and subjected them to oxidative stress for different time periods. Unlike the rod-shaped morphology of a normal myocyte ( Figure 1A ), hypercontracted morphology (rounded or irregular shaped) was observed in rSkMs exposed to H 2 O 2 ( Figure  1B ). Preconditioning with 200 mol/L DZ for 30 minutes prevented these morphological changes ( Figure 1C ) and hence was used throughout the study for preconditioning of rSkMs. LDH leakage was significantly reduced in PC rSkMs as compared with the non-PC rSkMs when both of these were exposed to H 2 O 2 (Pϭ0.017; Figure 1D ). Visualization of nuclei by 4Ј,6-diamidino-2-phenylindole (DAPI) revealed that most non-PC rSkMs had big, regular nuclei ( Figure 2A ). Exposure to oxidative stress caused chromatin condensation together with a shrunken morphology and reduced cell size ( Figure 2B ). These conditions were reverted to near normal in PC rSkMs ( Figure 2C ). Electron microscopy showed that preconditioning of rSkMs had no ill effects on cell morphology and ultrastructure organization ( Figure 2D and 2E). When treated with H 2 O 2 , non-PC rSkMs showed shriveled morphology. Their nuclei appeared shrunk and had dark, condensed chromatin network, and their mitochondria were swollen ( Figure 2F and 2G) . Preconditioning of rSkMs reversed these changes and the cells retained regular morphology and internal structures ( Figure 2H and 2I ). Injury to non-PC rSkMs in response to H 2 O 2 was aggravated in a timeand concentration-dependent manner (supplemental Figure I) .
TUNEL for DNA strand breaks in the terminal phase of apoptosis revealed that in comparison with the non-PC rSkMs, which exhibited a larger number of TUNEL-positive nuclei after exposure to 100 mol/L H 2 O 2 for 2 hours, the number of TUNEL-positive nuclei was significantly lower in the PC rSkMs ( Figure 3A through 3C) . The number of annexin V ϩ and PI-stained cells was significantly increased in the non-PC rSkMs as compared with the PC rSkMs on exposure to H 2 O 2 ( Figure 3D through 3F) . Immunostaining for cytochrome c revealed that mitochondrial localization of cytochrome c was characterized by punctate appearance in non-PC rSkMs ( Figure 4A) . Treatment of the non-PC rSkMs with 100 mol/L H 2 O 2 for 2 hours translocated cytochrome c into cytoplasm, which resulted in the loss of its punctate appearance to a homogeneous distribution in the cell cytoplasm ( Figure 4C ). Preconditioning of rSkMs before H 2 O 2 treatment protected their mitochondrial membrane integrity and prevented cytochrome c translocation into the cytoplasm ( Figure 4B ). DePsipher, a lipophilic cationic dye has the property of aggregating on membrane polarization to form orange red aggregate. In the event of membrane potential disruption, the dye cannot access the transmembranous space and remains or reverts to its green monomeric form. Staining of cells with DePsipher showed that preconditioning with DZ prevented the collapse of mitochondrial membrane potential (⌬m) in rSkMs after H 2 O 2 exposure (Figure 4D through 4F) .
Expression of Cell Survival Signaling Molecules and Growth Factors
The changes in the gene expression of several candidate molecules were assessed after treatment with H 2 O 2 and DZ by A through C, DAPI staining of rSkMs showed that in comparison with the nuclear size and morphology of the non-PC rSkMs (red arrows) (A), their exposure to H 2 O 2 caused nuclear shrinkage with condensed chromatin structure (yellow arrows) (B), whereas PC rSkMs retained nuclear size and morphology on exposure to H 2 O 2 (green arrows) (C). D and E, Ultrastructure studies showed that PC rSkMs had regular morphology, nucleus (n) with normal chromatin network, and mitochondria (m) with regular shape and normal cristae. F and G, Treatment with H 2 O 2 caused wrinkled morphology, condensed and marginated nuclear chromatin, shrunken nucleus, and swollen mitochondria with broken cristae. H and I, PC rSkMs on exposure to H 2 O 2 showed restored morphology, normal nuclear chromatin distribution, and normal mitochondria. E, G, and I are magnified images (ϫ50 000 magnification) of D, F, and H (ϫ5000 magnification), respectively. Figure  5A , upregulated expression of bFGF (1.44-fold) and HGF (2.26-fold) was observed in the PC rSkMs as compared with the non-PC rSkMs. These growth factors can initiate signaling pathways by binding to their cell surface receptor tyrosine kinases. We believe that one of the signaling circuitry involved in activation of these receptor tyrosine kinases is intracellular signaling along the phosphatidylinositol 3-kinase/Akt-dependent pathway. This is supported by the significantly higher level of phospho-Akt (1.85-fold) observed in cell lysates from PC rSkMs subjected to H 2 O 2 as compared with non-PC rSkMs treated with H 2 O 2 ( Figure 5C ). Consistent with this, we also found upregulated expression of cox-2 gene (1.33-fold) in the PC rSkMs ( Figure 5B ). Activation of phosphatidylinositol 3-kinase/Akt pathway by cox-2 to promote cell survival has been previously reported. 21 We did not observe a significant change in VEGF or Ang-1 expression in PC rSkMs, which suggested that previous reports demonstrating concomitant upregulation of VEGF with cox-2 occurred only under specific physiological condition like those in the tumor milieu. In summary, we propose that preconditioning of rSkMs promoted cell survival under oxidative stress by release of paracrine factors such as bFGF and HGF that will bind to their receptor tyrosine kinases to activate the phosphatidylinositol 3-kinase/Akt pathway.
RT-PCR and Western immunoblotting. As shown in
In Vivo Studies
All animals survived the full length of experiments. There were no deaths related with cell transplantation. Some animals (nϭ4 animals/group) were harvested 4 days after rSkM transplantation for molecular studies to assess survival of rSkM graft. The donor rSkMs survived well in both groups 2 and 3, as observed by standard PCR for rat sry gene in the female recipient heart. There was significantly higher survival of the male rSkMs in group 3 at 4 days after transplantation as compared with group 2 (PϽ0.05) ( Figure 6A ). No sry gene signals were observed in group 1. Real-time PCR further confirmed this trend in donor cell survival ( Figure 6B ). Immunostaining on rat heart tissue sections revealed a significantly higher number of Ki67-positive cells per surface area (0.036 mm 2 ) in the PC rSkM transplanted hearts as compared with non-PC rSkM-transplanted hearts ( Figure 6C through 6G). Immunostaining of the rat heart tissues for myogenic markers myosin heavy chain (fast skeletal isoform) revealed extensive neomyogenesis in the infarct and periinfarct regions in group 3. Confocal microscopy revealed that rSkMs participated in reparative process by undergoing myogenic differentiation in the infarct and periinfarct regions ( Figure 6H through 6J) . We did not observe connexin 43 
Heart Function Studies
Echocardiography results (nϭ7 animals/group) were compared between the control group 1 and experimental animal groups 2 and 3. LV function and remodeling indices are summarized in Figure 8A 
Discussion
Our study demonstrated that preconditioning was extremely effective to promote SkM survival under oxidative stress in vitro as well as in vivo. The major findings are: (1) preconditioning protected SkMs against oxidative stress via stimulation of the cell survival signaling mediators; (2) significantly enhanced rSkM survival in the infarcted myocardium; (3) release of paracrine factors from PC rSkMs promoted angiomyogenesis in the heart; and (4) improvement in the indices of LV heart function was significant in the PC rSkM-transplanted hearts. To our knowledge, this is the first study that has exploited preconditioning for enhanced survival and the paracrine effects of PC SkMs on angiomyogenesis in the ischemic myocardium.
Apoptosis has been implicated as among the mechanisms of cell death in the ischemic myocardium. Hence, developing strategy to alleviate apoptosis under ischemic stress is therefore of prime consequence in heart cell therapy. Indeed, possessing a vital role in cell bioenergetics and being key determinants of cell survival, mitochondria are the logical targets in pathological conditions to prevent cell apoptosis. Activation of mitochondrial pathways that promote cell survival is an endogenously occurring process of "ischemic preconditioning," as a part of the homeostasis. 22, 23 Apparently, a brief exposure to ischemia opens the mitochondrial ATP-sensitive potassium (mitoK ATP ) channels and renders the heart more tolerant to subsequent lethal ischemic injury. 24 Similar cytoprotective effects can be replicated by pharmacological agents that act on the mitoK ATP channels. 25 A chemically diverse group of compounds share the property of promoting K ϩ current through ATP-sensitive K ϩ channels. Among these, the prototype mitoK ATP channel opener DZ has been widely demonstrated to suppress cell apoptosis and promote cell survival. 26 The beneficial effects of DZ preconditioning have been reported in the heart and other organs. 27, 28 Indeed, pharmacological preconditioning now parallels ischemic preconditioning as among the most potent interventions to prevent apoptosis. Although the exact mechanism of cytoprotection remains contentious, these pharmacological agents act via multiple mechanisms. This may include succinate dehydrogenase inhibition, increased free radical production, mitochondrial depolarization, protein kinase C (PKC) activation and involvement of a potassium conductance-independent pathway for cellular protection. 17,29 -31 A possible role for the mitoK ATP channels in modulating complement gene expression in the ischemic myocardium has also been documented. 32 They prime the mitochondria to display uncouplingmediated glucose uptake and maintain mitochondrial ATP biosynthesis during ischemia, thus delaying ischemic cell death. 33 Defining the mechanistic link of DZ treatment with cytoprotection in cardiomyocytes, antiapoptotic properties of DZ have been exclusively attributed to mitoK ATP activation in a concentration-dependent manner. 34 Our group has already shown that cardiac protection from mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria. 35 The opening of mitoK ATP channels may act quite early in the apoptotic cascade by inhibiting cytochrome c release and depolarization, thus altering the earlier steps in the apoptotic cascade. We have reported that DZ-activated PKC␦ isoform translocation to mitochondria prompted phosphorylation-dependent activation of the channels. Moreover, mi- Figure 6 . A, Standard PCR for rat sry gene in female rat heart 4 days after male rSkM transplantation. Female rat heart in group 1 was used as negative control (lane 1), whereas male rSkMs were used as positive control (lane 4). Survival of rSkMs was higher in group 3 as compared with group 2 (PϽ0.05). B, Real-time PCR for sry gene showed a significant 1.93-fold increase in donor cell survival in group 3 as compared with group 2 (Pϭ0.04). C, Immunostaining revealed higher number of Ki67-positive cells in the PC rSkM-transplanted hearts (PϽ0.001) as compared with the non-PC rSkM-transplanted hearts. Confocal images showed PKH26-labeled PC rSkM transplanted in rat heart (red; D) with Ki67-positive nuclei (green) (E) counterstained with DAPI (blue) (F), respectively. White arrows in the merged image (G) show PKH26-labeled transplanted rSkMs staining positive for Ki67. H, Confocal images of the rat heart tissue in group 3 at 4 weeks after cell transplantation showed extensive localization of the surviving PKH-26 -labeled rSkMs in the scar area (red). I, Immunostaining revealed marked expression of myosin heavy chain (fast isoform) in the scar area (green). J, Merged image showed colocalization of red and green fluorescence indicative of myogenic differentiation of the grafted rSkMs.
toK ATP channels were not activated by DZ in PKCdownregulated hearts. 36 These findings received further support by our observation that DZ-induced cardiac protection was lost after using a specific PKC␦ inhibitor. 37 The primary goal of the present study was to investigate the effectiveness of DZ preconditioning for protection of rSkMs against oxidative stress. We conjectured that the protective effects afforded by DZ against apoptosis can be extrapolated to maximize cell graft viability in the infarcted heart. We observed a prodigious improvement in PC rSkM survival as compared with the non-PC rSkMs under oxidant stress in vitro. Parallel observations were made when rSkMs were transplanted in the infarcted rat heart. Based on rat sry gene detection, survival of the donor rSkMs was 1.93-fold higher in group 3 as compared with group 2 at 4 days after transplantation. Keeping in view that prognostic outcome of heart cell therapy is directly related with the number of cells injected, 4 these results are significant. In the previous studies, up to 1 billion cells have been injected during animal and human studies to compensate for the donor SkM loss post- Animal groups Figure 7 . Fluorescent immunostaining for capillary density assessment in the rat heart at 4 weeks after transplantation of PC or non-PC rSkMs. Rat heart tissue sections were immunostained for vWF VIII expression. A significant increase in blood vessel density was observed in infarct (A through C) and periinfarct (D through F) regions in group 3 as compared with groups 1 and 2 (G). Red fluorescence in B, C, E, and F shows the PKH-26 -labeled transplanted rSkMs.
transplantation. Propagation of SkMs to achieve this large number is time consuming and has economic and logistic implications in clinical settings. In the physiological context, dead cell debris contributes to the donor cell-specific humoral and local inflammatory responses at the site of cell graft. Prevention of the donor cell apoptosis will reduce the intensity of these reactions and create a favorable environment for the transplanted cells. The cytoprotective effects of DZ resulted in elevated expression of phospho-Akt and various growth factors that favored survival signaling, as activation of Akt and its downstream molecules are known for cytoprotection. 38 Therefore, it is logical to suggest that the upregulated levels of phospho-Akt and its downstream molecules in the PC rSkMs were at least in part responsible for the cytoprotective affects. Similarly, significantly improved blood vessel density observed in group 3 may be attributed to the elevated levels of growth factors with angiogenic potential in the PC rSkMs. Although there was some increase in VEGF and Ang-1 expression, more pronounced elevation was observed in bFGF and HGF expression in PC rSkMs. The role of bFGF in functionally significant angiogenesis has been well documented both in the animal and human studies. 39 Moreover, the cardioprotective effects of bFGF administration to the heart by perfusion in ischemia reperfusion injury to myocardium has also been reported. 40 We have already shown the antiapoptotic and angiogenic effects of HGF therapy in mice via Akt/phosphatidylinositol 3-kinase signaling. In light of these results, we infer a possible role for DZ preconditioninginduced bFGF and HGF stimulation of Akt signaling pathway in SkMs for their improved survival under oxidative stress.
In conclusion, we have demonstrated that preconditioning mimetics improve SkM tolerance to oxidative stress, which is associated with a high level expression of paracrine factors. We achieved similar results with human SkMs (our unpublished data, 2006) and mesenchymal stem cells. 38 With DZ already in clinical use and SkMs being used in clinical studies, their combined application may therefore be an exciting strategy for improved graft cell survival and angiomyogenesis during heart cell therapy. Figure 8 . Echocardiography for heart function analysis of rat heart 4 weeks after therapeutic intervention. There was significant improvement in LV function indices, including LV ejection fraction and LV fractional shortening, together with LV chamber dimensions and LV wall thickness in group 3 as compared with group 1 and group 2.
